The effects of aspirin on the outcome of COVID-19: A systematic review and meta-analysis - Clinical Epidemiology and Global Health
COVID-19 therapeutics: Challenges and directions for the future | PNAS
Aspirin | C9H8O4 | CID 2244 - PubChem
Full article: Low-dose aspirin for early COVID-19: does the early bird catch the worm?
Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS) | Archivos de Bronconeumología
Association of mortality and aspirin use for COVID-19 residents at VA Community Living Center Nursing Homes | medRxiv
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? | Drugs
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation | Nature Reviews Cardiology
Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis | SpringerLink
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry | Heart
Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? - Federico Cacciapuoti, Fulvio Cacciapuoti, 2021
Biomedicines | Free Full-Text | Aspirin and Infection: A Narrative Review
Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis - eClinicalMedicine
Therapeutic advances in COVID-19 | Nature Reviews Nephrology
Neurology International | Free Full-Text | Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities
Rationales and uncertainties for aspirin use in COVID-19: a narrative review | Family Medicine and Community Health
Frontiers | Aspirin in COVID-19: Pros and Cons
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection - The American Journal of Medicine
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial - British Journal of Anaesthesia
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents - The Lancet Infectious Diseases
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry | Journal of the American Heart Association
Could aspirin intake reduce mortality risk in COVID-19 patients?
Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia - The Lancet Respiratory Medicine
